Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q36702159)
Watch
English
Advances in Chagas disease drug development: 2009-2010
scientific article published on December 2010
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
3603362
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20885320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
title
Advances in Chagas disease drug development: 2009-2010
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
3603362
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20885320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
main subject
Chagas disease
0 references
author
Frederick S Buckner
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
3603362
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20885320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
author name string
Nazlee Navabi
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
3603362
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20885320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
publication date
1 December 2010
1 reference
stated in
Europe PubMed Central
PMC publication ID
3603362
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20885320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
published in
Current Opinion in Infectious Diseases
1 reference
stated in
Europe PubMed Central
PMC publication ID
3603362
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20885320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
volume
23
1 reference
stated in
Europe PubMed Central
PMC publication ID
3603362
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20885320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
issue
6
1 reference
stated in
Europe PubMed Central
PMC publication ID
3603362
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20885320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
page(s)
609-616
1 reference
stated in
Europe PubMed Central
PMC publication ID
3603362
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20885320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
cites work
In vitro and in vivo trypanocidal effects of the cyclopalladated compound 7a, a drug candidate for treatment of Chagas' disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Arylimidamide DB766, a potential chemotherapeutic candidate for Chagas' disease treatment
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Chagas disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
A nonazole CYP51 inhibitor cures Chagas' disease in a mouse model of acute infection
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Successful treatment with posaconazole of a patient with chronic Chagas disease and systemic lupus erythematosus
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Naftifine-analogues as anti-Trypanosoma cruzi agents
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Nitric oxide donor trans-[RuCl([15]aneN)NO] as a possible therapeutic approach for Chagas' disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Novel ruthenium complexes as potential drugs for Chagas's disease: enzyme inhibition and in vitro/in vivo trypanocidal activity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Nonpeptidic Tetrafluorophenoxymethyl Ketone Cruzain Inhibitors as Promising New Leads for Chagas Disease Chemotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Diamidine activity against trypanosomes: the state of the art.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Binding of nitrogen-containing bisphosphonates (N-BPs) to the Trypanosoma cruzi farnesyl diphosphate synthase homodimer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Biological, ultrastructural effect and subcellular localization of aromatic diamidines in Trypanosoma cruzi
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Two approaches to discovering and developing new drugs for Chagas disease.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
SAR studies on azasterols as potential anti-trypanosomal and anti-leishmanial agents
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Second generation of 2H-benzimidazole 1,3-dioxide derivatives as anti-trypanosomatid agents: synthesis, biological evaluation, and mode of action studies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
New, improved treatments for Chagas disease: from the R&D pipeline to the patients
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médecins Sans Frontières
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Experimental chemotherapy against Trypanosoma cruzi infection using ruthenium nitric oxide donors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Structurally simple inhibitors of lanosterol 14alpha-demethylase are efficacious in a rodent model of acute Chagas disease.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Synthesis and characterization of a pyridine-2-thiol N-oxide gold(I) complex with potent antiproliferative effect against Trypanosoma cruzi and Leishmania sp. insight into its mechanism of action
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Phase I/II evaluation of the prophylactic antimalarial activity of pafuramidine in healthy volunteers challenged with Plasmodium falciparum sporozoites.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Discovery of novel Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase inhibitors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Rational modification of a candidate cancer drug for use against Chagas disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Identification of three classes of heteroaromatic compounds with activity against intracellular Trypanosoma cruzi by chemical library screening
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Actions of a proline analogue, L-thiazolidine-4-carboxylic acid (T4C), on Trypanosoma cruzi
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Treatment of leishmaniasis with miltefosine: 2008 status
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Evaluation and treatment of chagas disease in the United States: a systematic review
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
African trypanosomiasis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
In vitro and in vivo activity of lignan lactones derivatives against Trypanosoma cruzi
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Novel azasterols as potential agents for treatment of leishmaniasis and trypanosomiasis.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Metal complexes as chemotherapeutic agents against tropical diseases: trypanosomiasis, malaria and leishmaniasis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Current treatment approaches to leishmaniasis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
30 September 2017
Effects of ravuconazole treatment on parasite load and immune response in dogs experimentally infected with Trypanosoma cruzi.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
28 June 2018
Antitrypanosomal activity of a diterpene and lignans isolated from Aristolochia cymbifera.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
28 June 2018
Trypanocidal activity and acute toxicity assessment of triterpene acids
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
28 June 2018
Chagas disease: pushing through the pipeline
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
5 September 2018
Effects of the calpain inhibitor MDL28170 on the clinically relevant forms of Trypanosoma cruzi in vitro
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
5 September 2018
A comparative study of posaconazole and benznidazole in the prevention of heart damage and promotion of trypanocidal immune response in a murine model of Chagas disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
5 September 2018
Reduction of parasitism tissue by treatment of mice chronically infected with Trypanosoma cruzi with lignano lactones.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
5 September 2018
In vitro susceptibility of Trypanosoma cruzi strains from Santander, Colombia, to hexadecylphosphocholine (miltefosine), nifurtimox and benznidazole.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
5 September 2018
In vitro and in vivo experimental models for drug screening and development for Chagas disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
5 September 2018
Antitrypanosomal and antileishmanial activities of novel N-alkyl-(1-phenylsubstituted-beta-carboline)-3-carboxamides
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
5 September 2018
The evaluation of quinonoid compounds against Trypanosoma cruzi: synthesis of imidazolic anthraquinones, nor-beta-lapachone derivatives and beta-lapachone-based 1,2,3-triazoles
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
5 September 2018
(-)-Hinokinin-loaded poly(D,-lactide-co-glycolide) microparticles for Chagas disease.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
5 September 2018
New potent 5-nitroindazole derivatives as inhibitors of Trypanosoma cruzi growth: synthesis, biological evaluation, and mechanism of action studies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
5 September 2018
The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
5 September 2018
Ergosterol biosynthesis and drug development for Chagas disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
5 September 2018
Trypanosoma cruzi: activity of heterocyclic cationic molecules in vitro
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
5 September 2018
In vitro effect of a new cinnamic acid derivative against the epimastigote form of Trypanosoma cruzi.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
5 September 2018
5-Nitro-2-furyl derivative actives against Trypanosoma cruzi: preliminary in vivo studies.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
5 September 2018
New potent imidazoisoquinolinone derivatives as anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
5 September 2018
Complexation of the anti-Trypanosoma cruzi drug benznidazole improves solubility and efficacy.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
5 September 2018
Neolignans from plants in northeastern Brazil (Lauraceae) with activity against Trypanosoma cruzi
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603362
retrieved
4 December 2018
The effects on Trypanosoma cruzi of novel synthetic naphthoquinones are mediated by mitochondrial dysfunction
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/20885320
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Peptide-fluoromethyl ketones arrest intracellular replication and intercellular transmission of Trypanosoma cruzi
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/20885320
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1097/QCO.0B013E3283402956
1 reference
stated in
Europe PubMed Central
PMC publication ID
3603362
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20885320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
PMC publication ID
3603362
1 reference
stated in
Europe PubMed Central
PMC publication ID
3603362
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20885320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
PubMed publication ID
20885320
1 reference
stated in
Europe PubMed Central
PMC publication ID
3603362
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20885320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit